- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Amgen bumps up pay for longtime CEO Robert Bradway 8% to $24.4M | ||
| Mo | Aurobindo gets Form 483 scolding from FDA at North Carolina inhaler plant | ||
| Mo | RFK Jr. blasts FDA as industry's 'sock puppet,' warns about 'deep state' influence at agency: Politico | ||
| Mo | Sandoz takes Amgen to court again, challenging its patents on decades-old Enbrel | ||
| Mo | In short reprieve for pharma, commerce secretary says drug tariffs to come 'in the next month or two' | ||
| Mo | 'Saturday Night Live' skewers drug ad tropes in Jon Hamm-led skit | ||
| Mo | Gilead reprimanded after PMCPA finds conference Wi-Fi sponsorship broke advertising rules | ||
| Mo | Theratechnologies juggles multiple suitors, including $255M offer from CDMO Future Pak | ||
| Fr | Navigating Retail and Specialty Lite Success: How Your Pharmacy Strategy Impacts Brand Performance | ||
| Fr | Amgen pads Imdelltra's case in tough-to-treat lung cancer subtype with phase 3 survival win | ||
| Fr | Bristol Myers combo follows Roche, AstraZeneca immunotherapy rivals into first-line liver cancer | ||
| Fr | After Hetlioz's rejection in jet lag disorder, Vanda sues FDA for right to promote off-label use | ||
| Fr | RFK Jr. looks to find cause of 'autism epidemic' by September through massive HHS research push | ||
| Fr | Argenx stays on a roll with Vyvgart, gaining FDA nod for at-home prefilled syringe | ||
| Fr | As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here to stay | ||
| Fr | Fierce Pharma Asia-Congress' US-China biotech report; NIH's database ban; GSK's ABL neuroscience deal | ||
| Fr | As work on massive US plant continues, Kyowa Kirin wraps up construction of $118M biologics plant in Japan | ||
| Do | Following pledges from Lilly and J&J, Novartis unveils $23B US investment to beef up manufacturing, R&D | ||
| Do | Alzheimer's Association expands PSA campaign about early dementia signs to focus on Black Americans | ||
| Do | Merck granted Rob Davis a pay boost to $23.2M, inching CEO's 2024 compensation closer to large pharma peers | ||
| Do | Sun Pharma snags appeals win over Incyte, clearing way for US launch of alopecia med Leqselvi | ||
| Do | Few psych drugs from past decade are on HCPs' radars: survey | ||
| Mi | CDMO PharmaLogic takes majority stake in Norway's Agilera to boost global radiopharma footprint | ||
| Mi | Annexon rolls out Guillain-Barré awareness campaign for HCPs amid promising results for targeted therapy | ||
| Mi | Mucinex maker Reckitt lets go of 190 staffers in NJ while Organon lays off 93 amid restructuring efforts |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
